You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Details for New Drug Application (NDA): 020165


✉ Email this page to a colleague

« Back to Dashboard


NDA 020165 describes NICODERM CQ, which is a drug marketed by Chattem Sanofi and is included in one NDA. It is available from four suppliers. Additional details are available on the NICODERM CQ profile page.

The generic ingredient in NICODERM CQ is nicotine. There are thirty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the nicotine profile page.
Summary for 020165
Tradename:NICODERM CQ
Applicant:Chattem Sanofi
Ingredient:nicotine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020165
Medical Subject Heading (MeSH) Categories for 020165
Suppliers and Packaging for NDA: 020165
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165 NDA Haleon US Holdings LLC 0135-0194 0135-0194-01 7 PATCH in 1 CARTON (0135-0194-01) / 24 h in 1 PATCH
NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165 NDA Haleon US Holdings LLC 0135-0194 0135-0194-02 14 PATCH in 1 CARTON (0135-0194-02) / 24 h in 1 PATCH

Profile for product number 004

Active Rx/OTC/Discontinued:OTCDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength21MG/24HR
Approval Date:Aug 2, 1996TE:RLD:Yes

Profile for product number 005

Active Rx/OTC/Discontinued:OTCDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength14MG/24HR
Approval Date:Aug 2, 1996TE:RLD:Yes

Profile for product number 006

Active Rx/OTC/Discontinued:OTCDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength7MG/24HR
Approval Date:Aug 2, 1996TE:RLD:Yes

Expired US Patents for NDA 020165

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-005 Aug 2, 1996 ⤷  Try a Trial ⤷  Try a Trial
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-005 Aug 2, 1996 ⤷  Try a Trial ⤷  Try a Trial
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-004 Aug 2, 1996 ⤷  Try a Trial ⤷  Try a Trial
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-006 Aug 2, 1996 ⤷  Try a Trial ⤷  Try a Trial
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-006 Aug 2, 1996 ⤷  Try a Trial ⤷  Try a Trial
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-006 Aug 2, 1996 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.